Swedbank AB Sells 80,418 Shares of The Cooper Companies, Inc. $COO

Key Points

• Swedbank AB reduced its stake in The Cooper Companies by 4.9%, holding approximately $130.67 million worth of shares after selling 80,418 shares during the first quarter.
• In the last quarter, company insiders purchased 15,975 shares valued at around $1.08 million, increasing their overall ownership to 1.98% of the stock.
• Cooper Companies reported a 5.7% increase in quarterly revenue year-over-year, with earnings per share of $1.10 exceeding analysts' expectations.

Swedbank AB lessened its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 4.9% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,549,184 shares of the medical device company's stock after selling 80,418 shares during the quarter. Swedbank AB owned about 0.77% of Cooper Companies worth $130,674,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in COO. Zions Bancorporation National Association UT acquired a new position in shares of Cooper Companies during the 1st quarter worth about $33,000. City Holding Co. acquired a new position in shares of Cooper Companies during the 1st quarter worth about $34,000. GKV Capital Management Co. Inc. acquired a new position in shares of Cooper Companies during the 1st quarter worth about $40,000. Larson Financial Group LLC lifted its position in shares of Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares during the last quarter. Finally, HM Payson & Co. lifted its position in shares of Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after purchasing an additional 532 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Insider Buying and Selling

In related news, CEO Albert G. White III bought 10,000 shares of the company's stock in a transaction dated Friday, September 5th. The stock was acquired at an average cost of $68.39 per share, with a total value of $683,900.00. Following the acquisition, the chief executive officer owned 226,151 shares in the company, valued at approximately $15,466,466.89. This represents a 4.63% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, COO Daniel G. Mcbride bought 3,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The stock was bought at an average cost of $65.04 per share, with a total value of $195,120.00. Following the completion of the acquisition, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. This represents a 4.99% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders acquired 15,975 shares of company stock valued at $1,079,566. 1.98% of the stock is currently owned by corporate insiders.

Cooper Companies Stock Performance

Cooper Companies stock traded up $2.42 during trading hours on Thursday, hitting $66.74. The stock had a trading volume of 1,011,285 shares, compared to its average volume of 2,296,540. The company has a 50-day moving average of $70.98 and a two-hundred day moving average of $75.48. The company has a quick ratio of 1.24, a current ratio of 2.12 and a debt-to-equity ratio of 0.29. The company has a market cap of $13.27 billion, a PE ratio of 32.87, a price-to-earnings-growth ratio of 1.71 and a beta of 0.97. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $112.29.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion during the quarter, compared to analysts' expectations of $1.06 billion. During the same quarter in the prior year, the firm posted $0.96 EPS. The company's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies declared that its Board of Directors has initiated a share buyback program on Wednesday, September 17th that authorizes the company to repurchase $2.00 billion in shares. This repurchase authorization authorizes the medical device company to purchase up to 15.4% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on COO shares. Needham & Company LLC reissued a "buy" rating and set a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. Robert W. Baird cut their price objective on Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research report on Thursday, August 28th. Loop Capital set a $100.00 price objective on Cooper Companies in a research report on Tuesday, June 17th. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. Finally, Mizuho cut their price objective on Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $86.64.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.